Holen Sie sich die Stockscreener-App
18.07
1.01%
0.18
Schlusskurs vom Vortag:
$17.89
Offen:
$18.03
24-Stunden-Volumen:
152.08K
Relative Volume:
0.88
Marktkapitalisierung:
$558.82M
Einnahmen:
$290.71M
Nettoeinkommen (Verlust:
$-163.43M
KGV:
-11.02
EPS:
-1.64
Netto-Cashflow:
$11.70M
1W Leistung:
+4.57%
1M Leistung:
-6.95%
6M Leistung:
-15.52%
1J Leistung:
-34.55%
1-Tages-Spanne:
$18.02
$18.63
1-Wochen-Bereich:
$16.92
$18.89
52-Wochen-Spanne:
$16.56
$30.68
Fulgent Genetics Inc Stock (FLGT) Company Profile
Firmenname
Fulgent Genetics Inc
Sektor
Branche
Telefon
626-350-0537
Adresse
4399 SANTA ANITA AVE, EL MONTE
Vergleichen Sie FLGT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
18.07 | 558.82M | 290.71M | -163.43M | 11.70M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-12-07 | Eingeleitet | UBS | Neutral |
| 2022-12-08 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Eingeleitet | Raymond James | Outperform |
| 2022-08-25 | Eingeleitet | Credit Suisse | Outperform |
| 2022-02-04 | Fortgesetzt | Piper Sandler | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Underperform |
| 2021-01-08 | Herabstufung | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Herabstufung | BTIG Research | Buy → Neutral |
| 2020-08-20 | Eingeleitet | Oppenheimer | Outperform |
| 2020-05-29 | Eingeleitet | BTIG Research | Buy |
| 2019-11-05 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Herabstufung | Raymond James | Outperform → Mkt Perform |
Alle ansehen
Fulgent Genetics Inc Aktie (FLGT) Neueste Nachrichten
Fulgent Genetics CEO Ming Hsieh sells $40,663 in stock - Investing.com
StockNews.com Downgrades Fulgent Genetics (NASDAQ:FLGT) to Sell - Defense World
Principal Financial Group Inc. Sells 6,020 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
When (FLGT) Moves Investors should Listen - Stock Traders Daily
All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy - MSN
10 Best Genomics Stocks To Buy Right Now - Insider Monkey
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month LowShould You Sell? - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by StockNews.com - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Trading Up 4% – Here’s Why - Defense World
Fulgent Genetics (NASDAQ:FLGT) Trading 4% HigherWhat's Next? - MarketBeat
Fulgent Genetics stock hits 52-week low at $18.76 By Investing.com - Investing.com Australia
Fulgent Genetics stock hits 52-week low at $18.76 - Investing.com
Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price - Defense World
Fulgent Genetics (NASDAQ:FLGT) Rating Lowered to “Sell” at StockNews.com - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript - Insider Monkey
(FLGT) Long Term Investment Analysis - Stock Traders Daily
Earnings call: Fulgent Genetics Q3 2024 results and growth strategies By Investing.com - Investing.com UK
Earnings call: Fulgent Genetics Q3 2024 results and growth strategies - Investing.com
Fulgent Genetics (NASDAQ:FLGT) Price Target Cut to $22.00 by Analysts at Piper Sandler - MarketBeat
Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth - Yahoo Finance
Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
State of Alaska Department of Revenue Has $247,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics (NASDAQ:FLGT) Trading Down 10.8%Time to Sell? - MarketBeat
Fulgent Genetics Reports Strong Q3 2024 Results - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline - Yahoo Finance UK
Fulgent Genetics Inc (FLGT) Quarterly 10-Q Report - Quartzy
Fulgent Reports Third Quarter 2024 Financial Results - BioSpace
Fulgent Genetics earnings beat by $0.46, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics (NASDAQ:FLGT) Updates FY24 Earnings Guidance - MarketBeat
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Fulgent Genetics Inc Reports Q3 2024 Earnings: Non-GAAP EPS of $0.31, Revenue at $71.7 Million - GuruFocus.com
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2024 Earnings Guidance - MarketBeat
Fulgent to Participate in Upcoming Conferences - Business Wire
Creative Planning Buys 8,075 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 5.6% in October - Defense World
Fulgent Genetics secures $99M VA contract for genetic testing By Investing.com - Investing.com Australia
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Positive week for Fulgent Genetics, Inc. (NASDAQ:FLGT) institutional investors who lost 20% over the past year - Simply Wall St
Fulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on Friday - Defense World
Fulgent Genetics (FLGT) to Release Earnings on Friday - MarketBeat
Fulgent Genetics secures $99M VA contract for genetic testing - Investing.com India
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 - BioSpace
Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week LowWhat's Next? - MarketBeat
Fulgent Genetics stock hits 52-week low at $18.9 amid market shifts - Investing.com
(FLGT) On The My Stocks Page - Stock Traders Daily
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 - BioSpace
Finanzdaten der Fulgent Genetics Inc-Aktie (FLGT)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.43%
0.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):